ESRA GOKTURK: Open Payments
NPI 1154598100 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 40 payments from 13 companies in 2025. Trend: 2023 $1,439 · 2024 $1,154 · 2025 $899
Food & beverage: $885Education: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $183 |
| PFIZER INC. | 8 | $143 |
| Bausch Health US, LLC | 6 | $127 |
| Novo Nordisk Inc | 4 | $88 |
| Lilly USA, LLC | 3 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Amgen Inc. | 2 | $28 |
| Becton, Dickinson and Company | 1 | $25 |
Products named: NURTEC ODT, QULIPTA, APLENZIN, TRINTELLIX, UBRELVY, ZEPBOUND, Wegovy, REXULTI.
Industry payments across VA — which companies pay providers there.
